E-LIB Suche - Ergebnisse für: Nakamatsu, K.

1

161P Intensity-modulated radiotherapy (IMRT)-adapted chemor..:

Hata, A. ; Harada, H. ; Konno, M....
ESMO Open. 9 (2024) - p. 102916 , 2024

Link: https://doi.org/10.1016/..

2

PO-1341 Failure patterns after stereotactic body radiothera..:

Doi, H. ; Inagaki, T. ; Inada, M....
Radiotherapy and Oncology. 182 (2023) - p. S1074-S1075 , 2023

Link: https://doi.org/10.1016/..

3

OA15.06 Differences in Pathologic Assessment by MPR Calcula..:

Kashima, J. ; Inamura, K. ; Hamada, A....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S80-S81 , 2023

Link: https://doi.org/10.1016/..

4

Major Cardiovascular Events after Chemoradiotherapy with or..:

Kokubo, M. ; Kishi, N. ; Matsuo, Y....
International Journal of Radiation Oncology*Biology*Physics. 117 (2023) 2 - p. e30-e31 , 2023

Link: https://doi.org/10.1016/..

5

Real-World Study of Overall Survival in Patients with Stage..:

Kishi, N. ; Matsuo, Y. ; Ogura, M....
International Journal of Radiation Oncology*Biology*Physics. 117 (2023) 2 - p. e29-e30 , 2023

Link: https://doi.org/10.1016/..

6

PO-1279 PFS and recurrence patterns after CCRT with durvalu..:

Kishi, N. ; Matsuo, Y. ; Shintani, T....
Radiotherapy and Oncology. 170 (2022) - p. S1077-S1078 , 2022

Link: https://doi.org/10.1016/..

7

124P Phase II study of neoadjuvant concurrent chemo-immuno-..:

Miyoshi, T. ; Hamada, A. ; Soh, J....
Immuno-Oncology and Technology. 16 (2022) - p. 100236 , 2022

Link: https://doi.org/10.1016/..

8

Serum Lactate Dehydrogenase is a Predictive Biomarker in Or..:

Uehara, T. ; Doi, H. ; Ishikawa, K....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. e397-e398 , 2021

Link: https://doi.org/10.1016/..

9

PO-1173 Previous pneumectomy is a risk factor of severe rad..:

Tatsuno, S. ; Doi, H. ; Okada, W....
Radiotherapy and Oncology. 161 (2021) - p. S973 , 2021

Link: https://doi.org/10.1016/..

10

EP-1340 Lactate dehydrogenase predicts survival in small ce..:

AnamI, S. ; Doi, H. ; Nakamatsu, K....
Radiotherapy and Oncology. 133 (2019) - p. S734 , 2019

Link: https://doi.org/10.1016/..

11

EP-1336 Immunogenic prognostic factors in patients with bra..:

Doi, H. ; Nakamatsu, K. ; Anami, S....
Radiotherapy and Oncology. 133 (2019) - p. S732 , 2019

Link: https://doi.org/10.1016/..

12

EP-1293: Clinical outcome of prophylactic PAN irradiation f..:

Fukuda, K. ; Nishimura, Y. ; Nakamatsu, K.
Radiotherapy and Oncology. 123 (2017) - p. S694 , 2017

Link: https://doi.org/10.1016/..

13

Dosimetry Comparison Between Intraoperatively Built Custom ..:

Inada IV, M. ; Nakamatsu, K. ; Ishikawa, K..
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 2 - p. E241 , 2017

Link: https://doi.org/10.1016/..

14

Anatomical and Dosimetric Changes during IMRT for Oropharyn..:

Ishikawa, K. ; Inada IV, M. ; Fukuda, K....
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 2 - p. E342 , 2017

Link: https://doi.org/10.1016/..

15

Pharyngeal Constrictor Muscle (PCM) Sparing and Dysphagia T..:

Ishikawa, K. ; Inada III, M. ; Fukuda, K....
International Journal of Radiation Oncology*Biology*Physics. 96 (2016) 2 - p. E381 , 2016

Link: https://doi.org/10.1016/..